Last edition
News about "epilepsy "
Xenon Submits NDA for Azetukalner in Focal Seizures to US FDA
Xenon Pharmaceuticals has submitted an NDA to the US FDA for azetukalner in focal seizures, supported by data from the Phase 2b X-TOLE and Phase 3 X-TOLE2 trials.
Epilepsy | 21/09/2026 | By News Bureau | 132
PannTheraPi Gets French Approval to Advance PTI5803 into Phase 2a Epilepsy Trial
PannTheraPi will evaluate PTI5803 across three dose levels, focusing on safety, tolerability and preliminary efficacy in patients with drug-resistant focal cortical dysplasia-associated epilepsy.
Epilepsy | 09/09/2026 | By News Bureau | 194
Akums Highlights Lacosamide's Versatility in Epilepsy Management
Akums Drugs & Pharmaceuticals reaffirmed lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings.
Epilepsy | 22/09/2025 | By Dineshwori | 261
Jazz and Saniona Enter Global License Deal for Preclinical Epilepsy Candidate SAN2355
Jazz Pharmaceuticals and Saniona have entered into a global licensing agreement, giving Jazz exclusive worldwide rights to develop and commercialise SAN2355, a highly selective Kv7.2/Kv7.3 activator currently in preclinical development for epilepsy and other neurological conditions. <br />
Epilepsy | 21/08/2025 | By Dineshwori | 388
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy